Acupuncture treatment of lung-spleen Qi deficiency in stable chronic obstructive pulmonary disease: a randomized, open-label, controlled trial

被引:0
|
作者
Li Yu [1 ]
Xiong Chan [1 ]
Zeng Yan [1 ]
Wei Hua [1 ]
Zhuang Guangtong [2 ]
Zhao Lihong [1 ]
Li Chenyi [1 ]
Li Lin [3 ]
Qin Erqi [3 ]
Chen Xiaoqin [3 ]
Fu Juanjuan [4 ]
机构
[1] Respiratory Department,No.3 Affiliated Hospital of Chengdu University of Traditional Chinese Medicine (West District),Chengdu Pidu District Hospital of Traditional Chinese Medicine
[2] Department of Integrated Traditional and Western Medicine,West China Hospital,Sichuan University
[3] Cardiovascular Department,No.3 Affiliated Hospital of Chengdu University of Traditional Chinese Medicine(West District),Chengdu Pidu District Hospital of Traditional Chinese Medicine
[4] Department of Research,No.3 Affiliated Hospital of Chengdu University of Traditional Chinese Medicine (West District),Chengdu Pidu District Hospital of Traditional Chinese Medicine
关键词
Acupuncture; Pulmonary disease; chronic obstructive; Randomized controlled trial; Symptoms and signs;
D O I
10.19852/j.cnki.jtcm.2019.06.016
中图分类号
R563.9 [其他];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE: To evaluate the effectiveness and safety of acupuncture that reinforces the spleen to strengthen the lung in patients with stable chronic obstructive pulmonary disease(COPD).METHODS: This was a randomized, open-controlled trial in which the acupuncturist and the participants were not blinded, but the outcome evalu-ators and data analysts were blinded. One-hundred-and-two patients with stable COPD were randomly divided into two groups in a 1∶1 ratio. The acupuncture group received 30-minute sessions of acupuncture therapy at the same acupoints three times weekly for 6 weeks in addition to routine conventional Western Medicine treatment; the control group received routine conventional Western Medicine treatment alone. The primary outcome was the Borg scale score, which was assessed immediately after the 6-minute walk test. The secondary outcomes were the 6-minute walk distance, lung function, and oxygen saturation. Measurements were obtained at baseline and after 6 weeks of treatment.RESULTS: After 6 weeks of treatment, the Borg scale score in the acupuncture group was significantly better than that in the control group(2.02 ±0.71 versus 5.01 ± 0.34, P < 0.05). Furthermore, the post-treatment improvements in the 6-minute walk distance, lung function, and oxygen saturation were significantly greater in the acupuncture group than in the control group, showing that the acupuncture group had better exercise tolerance.CONCLUSION: The findings suggest that acupuncture that aims to reinforce the spleen to strengthen the lung is a safe and effective adjuvant therapy that effectively improves the exercise capacity of patients with stable COPD.
引用
收藏
页码:885 / 891
页数:7
相关论文
共 50 条
  • [21] Autologous Transplantation of P63+Lung Progenitor Cells for Chronic Obstructive Pulmonary Disease Therapy: An Open-label, Controlled, First-in-Human Trial
    Zhang, T.
    Wang, Y.
    Zhou, Y.
    Zhao, Y.
    Zuo, W.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [22] A Randomized, Placebo-Controlled Trial of Acupuncture in Patients With Chronic Obstructive Pulmonary Disease (COPD) The COPD-Acupuncture Trial (CAT)
    Suzuki, Masao
    Muro, Shigeo
    Ando, Yuki
    Omori, Takashi
    Shiota, Tetsuhiro
    Endo, Kazuo
    Sato, Susumu
    Aihara, Kensaku
    Matsumoto, Masataka
    Suzuki, Shinko
    Itotani, Ryo
    Ishitoko, Manabu
    Hara, Yoshikazu
    Takemura, Masaya
    Ueda, Tetsuya
    Kagioka, Hitoshi
    Hirabayashi, Masataka
    Fukui, Motonari
    Mishima, Michiaki
    ARCHIVES OF INTERNAL MEDICINE, 2012, 172 (11) : 878 - 886
  • [23] Effects of comprehensive therapy based on traditional Chinese medicine patterns in stable chronic obstructive pulmonary disease: a four-center, open-label, randomized, controlled study
    Li, Su-yun
    Li, Jian-sheng
    Wang, Ming-hang
    Xie, Yang
    Yu, Xue-qing
    Sun, Zi-kai
    Ma, Li-jun
    Zhang, Wei
    Zhang, Hai-long
    Cao, Fan
    Pan, Ying-chao
    BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2012, 12
  • [24] Effects of comprehensive therapy based on traditional Chinese medicine patterns in stable chronic obstructive pulmonary disease: a four-center, open-label, randomized, controlled study
    Su-yun Li
    Jian-sheng Li
    Ming-hang Wang
    Yang Xie
    Xue-qing Yu
    Zi-kai Sun
    Li-jun Ma
    Wei Zhang
    Hai-long Zhang
    Fan Cao
    Ying-chao Pan
    BMC Complementary and Alternative Medicine, 12
  • [25] Acupuncture for patients with mild hypertension: study protocol of an open-label multicenter randomized controlled trial
    Juan Li
    Hui Zheng
    Ling Zhao
    Ying Li
    Yan Zhang
    Xiao-rong Chang
    Rui-hui Wang
    Jing Shi
    Jin Cui
    Yin-lan Huang
    Xiang Li
    Jie Chen
    De-hua Li
    Fan-rong Liang
    Trials, 14
  • [26] Acupuncture for patients with mild hypertension: study protocol of an open-label multicenter randomized controlled trial
    Li, Juan
    Zheng, Hui
    Zhao, Ling
    Li, Ying
    Zhang, Yan
    Chang, Xiao-rong
    Wang, Rui-hui
    Shi, Jing
    Cui, Jin
    Huang, Yin-lan
    Li, Xiang
    Chen, Jie
    Li, De-hua
    Liang, Fan-rong
    TRIALS, 2013, 14
  • [27] EFFECT OF CILOSTAZOL TO DECREASE ENDOTHELIAL DYSFUNCTION IN CHRONIC KIDNEY DISEASE: A RANDOMIZED, OPEN-LABEL CONTROLLED TRIAL
    Thookhamme, Ompan
    Nata, Naowanit
    Tasanavipas, Pamila
    Varothai, Narittaya
    Supasyndh, Ouppatham
    Satirapoj, Bancha
    NEPHROLOGY, 2023, 28 : 63 - 64
  • [28] Lung Deflation and Cardiovascular Structure and Function in Chronic Obstructive Pulmonary Disease A Randomized Controlled Trial
    Stone, Ian S.
    Barnes, Neil C.
    James, Wai-Yee
    Midwinter, Dawn
    Boubertakh, Redha
    Follows, Richard
    John, Leonette
    Petersen, Steffen E.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193 (07) : 717 - 726
  • [29] Treatment of pulmonary mucormycosis with adjunctive nebulized amphotericin B (MUCONAB trial): Results of an open-label randomized controlled trial
    Muthu, Valliappan
    Gogineni, Ratnakara Rao
    Agarwal, Ritesh
    Prasad, Kuruswamy Thurai
    Sehgal, Inderpaul Singh
    Dhooria, Sahajal
    Aggarwal, Ashutosh N.
    Rudramurthy, Shivaprakash Mandya
    Singh, Harkant
    Garg, Mandeep
    Chakrabarti, Arunaloke
    MYCOSES, 2023, 66 (08) : 688 - 696
  • [30] A randomized, open-label, controlled trial of gabapentin and phenobarbital in the treatment of alcohol withdrawal
    Mariani, JJ
    Rosenthal, RN
    Tross, S
    Singh, P
    Anand, OP
    AMERICAN JOURNAL ON ADDICTIONS, 2006, 15 (01): : 76 - 84